Skip to main content
. Author manuscript; available in PMC: 2012 Jan 24.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Jan 28;66(5):927–933. doi: 10.1007/s00280-010-1242-z

Table 3. All regimen related grade 3/4 toxicity.

Toxicity # Episodes
Hematologic
 Granulocytes <1,000/μl 5
 Platelet nadir <50,000/μl 6
 Requiring transfusion 3
Nausea/vomiting
 Intractable (grade 3) 1
Venous thrombosis 2